A detailed history of National Asset Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, National Asset Management, Inc. holds 98,183 shares of JNJ stock, worth $14.3 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
98,183
Previous 117,250 16.26%
Holding current value
$14.3 Million
Previous $17.1 Million 7.15%
% of portfolio
0.45%
Previous 0.45%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 13, 2024

SELL
$145.48 - $167.38 $2.77 Million - $3.19 Million
-19,067 Reduced 16.26%
98,183 $15.9 Million
Q2 2024

Aug 19, 2024

SELL
$144.38 - $157.78 $4.51 Million - $4.93 Million
-31,236 Reduced 21.04%
117,250 $17.1 Million
Q1 2024

May 16, 2024

BUY
$155.22 - $162.74 $1.06 Million - $1.11 Million
6,802 Added 4.8%
148,486 $23.5 Million
Q4 2023

Mar 15, 2024

SELL
$145.6 - $158.88 $990,371 - $1.08 Million
-6,802 Reduced 4.58%
141,684 $22.2 Million
Q3 2023

Dec 01, 2023

SELL
$155.75 - $174.48 $127,247 - $142,550
-817 Reduced 0.55%
148,486 $23.1 Million
Q2 2023

Jul 27, 2023

SELL
$154.35 - $166.11 $1.45 Million - $1.56 Million
-9,371 Reduced 5.91%
149,303 $24.7 Million
Q1 2023

May 17, 2023

SELL
$151.05 - $180.26 $1.31 Million - $1.56 Million
-8,644 Reduced 5.17%
158,674 $24.6 Million
Q4 2022

Mar 15, 2023

SELL
$160.2 - $179.79 $164,845 - $185,003
-1,029 Reduced 0.61%
167,318 $29.6 Million
Q4 2022

Feb 21, 2023

BUY
$160.2 - $179.79 $1.18 Million - $1.32 Million
7,335 Added 4.56%
168,347 $29.7 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $9.07 Million - $10.1 Million
56,251 Added 53.69%
161,012 $26.3 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $941,023 - $1.04 Million
-5,595 Reduced 5.07%
104,761 $18.6 Million
Q1 2022

May 02, 2022

SELL
$158.14 - $179.59 $534,671 - $607,193
-3,381 Reduced 2.97%
110,356 $19.6 Million
Q4 2021

Jan 28, 2022

SELL
$155.93 - $173.01 $162,167 - $179,930
-1,040 Reduced 0.91%
113,737 $19.5 Million
Q3 2021

Nov 16, 2021

BUY
$161.5 - $179.47 $350,616 - $389,629
2,171 Added 1.93%
114,777 $18.6 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $852,261 - $914,198
5,344 Added 4.98%
112,606 $18.5 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $5.73 Million - $6.38 Million
37,442 Added 53.63%
107,262 $17.6 Million
Q4 2020

Feb 04, 2021

SELL
$137.11 - $157.38 $3.14 Million - $3.61 Million
-22,935 Reduced 24.73%
69,820 $11 Million
Q3 2020

Nov 09, 2020

BUY
$140.38 - $153.83 $2.25 Million - $2.47 Million
16,035 Added 20.9%
92,755 $13.7 Million
Q2 2020

Jul 31, 2020

SELL
$128.81 - $155.51 $93,902 - $113,366
-729 Reduced 0.94%
76,720 $10.8 Million
Q1 2020

May 06, 2020

BUY
$111.14 - $153.99 $1.84 Million - $2.54 Million
16,517 Added 27.11%
77,449 $10.2 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $422,280 - $485,009
3,312 Added 5.75%
60,932 $8.89 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $94,577 - $105,894
745 Added 1.31%
57,620 $7.46 Million
Q2 2019

Aug 05, 2019

BUY
$131.15 - $144.24 $593,847 - $653,118
4,528 Added 8.65%
56,875 $7.93 Million
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $11,817 - $13,140
-94 Reduced 0.18%
52,347 $7.32 Million
Q4 2018

Feb 08, 2019

SELL
$122.84 - $147.84 $160,920 - $193,670
-1,310 Reduced 2.44%
52,441 $6.77 Million
Q3 2018

Nov 08, 2018

BUY
$121.58 - $142.88 $137,993 - $162,168
1,135 Added 2.16%
53,751 $7.43 Million
Q2 2018

Oct 05, 2018

BUY
$119.4 - $131.76 $275,694 - $304,233
2,309 Added 4.59%
52,616 $6.39 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $661,028 - $782,771
-5,284 Reduced 9.51%
50,307 $6.45 Million
Q4 2017

Feb 15, 2018

BUY
$131.22 - $143.62 $239,476 - $262,106
1,825 Added 3.39%
55,591 $7.77 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $380,641 - $398,017
2,940 Added 5.78%
53,766 $6.99 Million
Q2 2017

Aug 15, 2017

BUY
N/A
50,826
50,826 $6.73 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.